FDA approves new painkiller that shows promise and challenges of opioid alternatives
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for ...
FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
WBUR3d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals ... It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering ...
FDA approves painkiller said to thwart addiction
Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...
Indiatimes2d
US FDA approves new painkiller Journavx as alternative to opioids
approved Vertex Pharmaceuticals' drug, Journavx, for short-term pain relief following surgery or injuries. This is the first new pharmaceutical approach to pain treatment in over 20 years ...
Nasdaq3d
FDA Approves Vertex Pharma's JOURNAVX As The First Drug In A New Class Of Non-Opioid Pain Medicines
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX ... oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years. The most recent pain medication approved ...
Rebecca Yarros’s ‘Onyx Storm’ Is the Fastest-Selling Adult Novel in 20 Years
The book, the third in a series, has sold 2.7 million copies in its first week, and provided yet another example of the ...